Exact Mass: 296.1525

Exact Mass Matches: 296.1525

Found 45 metabolites which its exact mass value is equals to given mass value 296.1525, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

6-allyl-8b-Carboxy-ergoline

(2S,7S)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxylic acid

C18H20N2O2 (296.1525)


6-allyl-8b-Carboxy-ergoline is a metabolite of cabergoline. Cabergoline (brand names Dostinex and Cabaser), an ergot derivative, is a potent dopamine receptor agonist on D2 receptors. In vitro, rat studies show cabergoline has a direct inhibitory effect on pituitary lactotroph cells. It is frequently used as a first-line agent in the management of prolactinomas due to higher affinity for D2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine. (Wikipedia)

   

Desethylibophyllidine

Desethylibophyllidine

C18H20N2O2 (296.1525)


   

(+)-Piperazinomycin

(+)-Piperazinomycin

C18H20N2O2 (296.1525)


   

8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol

8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol

C18H20N2O2 (296.1525)


   

N-(4-benzamidobutyl)benzamide

N-(4-benzamidobutyl)benzamide

C18H20N2O2 (296.1525)


   

(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A

(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A

C18H20N2O2 (296.1525)


   

Piperazinomycin

Piperazinomycin

C18H20N2O2 (296.1525)


   

8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin

8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin

C18H20N2O2 (296.1525)


   

Albanitrile G

2,17-Dihydroxyoctadeca-6,8,10-triynedinitrile

C18H20N2O2 (296.1525)


   

3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline

3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline

C18H20N2O2 (296.1525)


   
   

1,2-Dibenzoyl-1-tert-butylhydrazine

1,2-Dibenzoyl-1-tert-butylhydrazine

C18H20N2O2 (296.1525)


   

Guanethidine sulfate

Guanethidine monosulfate

C10H24N4O4S (296.1518)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents

   

(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE

(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE

C18H20N2O2 (296.1525)


   

4,4-bis(dimethylamino)benzil

4,4-bis(dimethylamino)benzil

C18H20N2O2 (296.1525)


   

benzyl 2-phenylpiperazine-1-carboxylate

benzyl 2-phenylpiperazine-1-carboxylate

C18H20N2O2 (296.1525)


   

Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate

Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate

C18H20N2O2 (296.1525)


   

benzyl 3-phenylpiperazine-1-carboxylate

benzyl 3-phenylpiperazine-1-carboxylate

C18H20N2O2 (296.1525)


   

(8β)-6-Allylergoline-8-carboxylic acid

(8β)-6-Allylergoline-8-carboxylic acid

C18H20N2O2 (296.1525)


   

2-(4-BENZYL-PIPERAZIN-1-YL)-BENZOIC ACID

2-(4-BENZYL-PIPERAZIN-1-YL)-BENZOIC ACID

C18H20N2O2 (296.1525)


   

4-(1-Benzylpyrrolidin-3-yloxy)benzamide

4-(1-Benzylpyrrolidin-3-yloxy)benzamide

C18H20N2O2 (296.1525)


   

2-(1H-INDOL-3-YL)-2-PHENYL-ETHYLAMINE

2-(1H-INDOL-3-YL)-2-PHENYL-ETHYLAMINE

C18H20N2O2 (296.1525)


   

3-(4-BENZYL-PIPERAZIN-1-YL)-BENZOIC ACID

3-(4-BENZYL-PIPERAZIN-1-YL)-BENZOIC ACID

C18H20N2O2 (296.1525)


   

N,N-BIS(SALICYLIDENE)-1,4-BUTANEDIAMINE

N,N-BIS(SALICYLIDENE)-1,4-BUTANEDIAMINE

C18H20N2O2 (296.1525)


   

4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine

4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine

C18H20N2O2 (296.1525)


   

4-(4-Benzyl-1-piperazinyl)benzoic acid

4-(4-Benzyl-1-piperazinyl)benzoic acid

C18H20N2O2 (296.1525)


   

[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol

[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol

C18H20N2O2 (296.1525)


   

4-methyl-N-[4-(4-morpholinyl)phenyl]benzamide

4-methyl-N-[4-(4-morpholinyl)phenyl]benzamide

C18H20N2O2 (296.1525)


   

1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea

1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea

C18H20N2O2 (296.1525)


   

(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone

(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone

C18H20N2O2 (296.1525)


   

1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole

1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole

C18H20N2O2 (296.1525)


   

1-(2-Azocan-1-ylethyl)guanidine sulfate

1-(2-Azocan-1-ylethyl)guanidine sulfate

C10H24N4O4S (296.1518)


   

(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one

(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one

C18H20N2O2 (296.1525)


   

(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one

(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one

C18H20N2O2 (296.1525)


   

6-allyl-8b-Carboxy-ergoline

6-allyl-8b-Carboxy-ergoline

C18H20N2O2 (296.1525)


   

SN40

SN40

C18H20N2O2 (296.1525)


SN40 is a potent amino acid transport (AAT) inhibitor with Kis of 7.29 μM, 2.42 μM, 2.94 μM, 5.55 μM, 24.43 μM and 5.55 μM for rat ASCT2, human ASCT2, EAAT1, EAAT2, EAAC1 and EAAT5, respectively. SN40 can be used for researching anticancer[1].

   

(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one

(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one

C18H20N2O2 (296.1525)


   

(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one

(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one

C18H20N2O2 (296.1525)


   

(1r,13s,16r)-16-hydroxy-5,14-diazapentacyclo[12.3.3.0¹,¹³.0⁴,¹².0⁶,¹¹]icosa-4(12),6,8,10-tetraen-15-one

(1r,13s,16r)-16-hydroxy-5,14-diazapentacyclo[12.3.3.0¹,¹³.0⁴,¹².0⁶,¹¹]icosa-4(12),6,8,10-tetraen-15-one

C18H20N2O2 (296.1525)


   

8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol

8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol

C18H20N2O2 (296.1525)


   

13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol

13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol

C18H20N2O2 (296.1525)


   

(3s,6s)-13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol

(3s,6s)-13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol

C18H20N2O2 (296.1525)


   

(5as,13r)-8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol

(5as,13r)-8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol

C18H20N2O2 (296.1525)


   

n-(4-{[hydroxy(phenyl)methylidene]amino}butyl)benzenecarboximidic acid

n-(4-{[hydroxy(phenyl)methylidene]amino}butyl)benzenecarboximidic acid

C18H20N2O2 (296.1525)


   

4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one

4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one

C18H20N2O2 (296.1525)